Michael Comb, Ph.D.

Michael is President and CEO of Cell Signaling Technology (CST), he leads CST’s efforts to build the best antibody technology in the world for researchers working to understand the molecular and cellular processes of disease. He founded the company to provide the research community with tools that he himself had sought as an investigator. Before starting CST in 1999, he directed the Molecular Neurobiology Lab at Massachusetts General Hospital and served as an Associate Professor of Neuroscience at Harvard Medical School.

Michael holds a B.S. in chemistry from the University of Massachusetts and a Ph.D. in chemistry from the University of Oregon. He has published more than 60 peer-reviewed scientific articles and is the inventor on numerous patents and patent applications. Michael is passionate about supporting our communities, inspiring the next generation of scientists, and protecting the environment.